According to WHO, cardiovascular diseases (CVDs), at a global level, are the number 1 cause of death, estimating around 17.9 million lives lost each year. Four out of five CVD deaths are due to heart attacks and strokes (almost 85%), and one-third of these occur In people under 70 years of age. There are many risk factors associated with coronary heart disease and stroke. Some of them, such as family history, cannot be modified, while others like high blood pressure, high cholesterol, life habits, etc can be adjusted and kept under control.

Moving away from the most known approaches for CVDs prevention, science has developed another strategy, aiming to support heart health by the use of probiotics, which highlights the connection between gut microbiota and cardiovascular health (the Gut – Heart Axis).

ROELMI HPC expert of probiotic ingredients, has designed and developed a probiotic complex that, showed to be a valid support in reducing the risk linked to the development of CVDs. Discover SynBalance® probiotics, the friendly bacteria selected for their intrinsic functional properties and improved in terms of stability in order to give the best performance once formulated.

Read the full article from Nutracos

Read more